Date of death - estimated.Date of event - estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Date of implant - estimated.The device was not returned for evaluation.A review of the lot history record could not be conducted because the part and lot number was not provided.The reported patient effect of death is listed in the xience v everolimus eluting coronary stent systems instructions for use (ifu) as a known patient effect of coronary procedures.A conclusive cause for the reported death and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Literature: randomized comparison of everolimus- and zotarolimus-eluting coronary stents with biolimus-eluting stents in all-comer patients the other adverse events mentioned in the article are filed under a separate medwatch mfr number.
|
This is filed to report patient deaths.It was reported in a research article that xience stents may be related to death, myocardial infarction, stent thrombosis, and re-vascularization.Specific patient information was not provided.Details can be found in the article "randomized comparison of everolimus- and zotarolimus-eluting coronary stents with biolimus-eluting stents in all-comer patients" see article for additional information.
|